Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Winning Combination

Hans Ole Klingenberg at Novozymes Biopharma extols the virtues of combined hyaluronic acid and API formulations for treating osteoarthritis offering patients a more effective treatment, easier administration and longer-term drug retention.

Hans Ole Klingenberg, Novozymes Biopharma (March 2014)

Keywords: Osteoarthritis, Hyaluronic acid, Bacillus subtilis, Combination products, Controlled release formulation

    View full article    |    Back to Delivery systems section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |